Excessive matrix metalloproteinase-9 in the plasma of community-acquired pneumonia

Clin Chim Acta. 2005 Feb;352(1-2):209-15. doi: 10.1016/j.cccn.2004.09.025.

Abstract

Background: It has been shown that matrix metalloproteinase-9 (MMP-9) is involved in the pathogenesis of various pulmonary inflammatory diseases. We determined the MMP-9 concentration in the plasma of community-acquired pneumonia (CAP) patients before and after antibiotic treatment.

Methods: Gelatin zymography and ELISA analysis were used to measure MMP-9 activity and MMP-9 level, respectively, in 35 control subjects and 46 CAP patients.

Results: WBC counts, neutrophils, MMP-9 activity and MMP-9 level were significantly higher in CAP patients compared with that of control subjects (P<0.001), while MMP-9 activity and MMP-9 level were returned to normal after the antibiotic treatment (P<0.001). In addition, MMP-9 level correlated positively with WBC counts and neutrophils number both before and after the antibiotic treatment.

Conclusions: MMP-9 may play an important role in the pathogenesis of CAP with a positive correlation with the number of neutrophils.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Anti-Bacterial Agents / therapeutic use
  • Community-Acquired Infections / blood
  • Community-Acquired Infections / drug therapy
  • Community-Acquired Infections / enzymology*
  • Female
  • Humans
  • Male
  • Matrix Metalloproteinase 9 / blood*
  • Middle Aged
  • Pneumonia / blood*
  • Pneumonia / drug therapy
  • Pneumonia / enzymology*

Substances

  • Anti-Bacterial Agents
  • Matrix Metalloproteinase 9